ClinicalTrials.Veeva

Menu

Efficacy and Safety of Astaxanthin in Volunteer With Refraction Errors

C

Chulalongkorn University

Status

Unknown

Conditions

Refractive Errors

Treatments

Dietary Supplement: astaxanthin 4 mg
Dietary Supplement: astaxanthin 6 mg
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT05009810
EC2103320

Details and patient eligibility

About

This study will investigate efficacy and safety of astaxanthin in 180 volunteers with refraction errors. Visual test, skin test, liver function test, renal function test, and adverse event will be evaluated before and after taking astaxanthin for 1 and 2 months.

Full description

This study will investigate efficacy and safety of astaxanthin in 180 volunteers with refraction errors. They will divided into 3 groups which are astaxanthin 4 mg group , astaxanthin 6 mg group, and placebo group. They will take the sample 1 capsule once daily for 2 months. Visual test, skin test, liver function test, renal function test, and adverse event will be evaluated before and after taking the sample for 1 and 2 months.

Enrollment

180 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18-65 years
  • Refraction errors, dry eye, or blurred vision
  • Have a willingness to participate in the study

Exclusion criteria

  • Uncontrolled disease
  • Have complications during the study
  • Have astaxanthin more than 2 weeks
  • Allergic to astaxanthin, seafood, or seaweed
  • Osteoporosis or thyroid disease
  • Immunodeficiency or taking immunosuppressants
  • Liver and kidney diseases
  • A person with a brain disorder, vision or hearing unusual
  • Pregnancy or lactation
  • Cannot follow the protocol
  • During participated in other studies

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

180 participants in 3 patient groups, including a placebo group

astaxanthin 4 mg
Experimental group
Description:
The astaxanthin 4 mg will be taken 1 capsule once daily for 2 months.
Treatment:
Dietary Supplement: astaxanthin 4 mg
astaxanthin 6 mg
Experimental group
Description:
The astaxanthin 6 mg will be taken 1 capsule once daily for 2 months.
Treatment:
Dietary Supplement: astaxanthin 6 mg
Placebo
Placebo Comparator group
Description:
The placebo will be taken 1 capsule once daily for 2 months.
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems